More than 8 months since the pandemic began, we now have a clearer picture of how COVID-19 affects people with cancer.
Researchers have found an existing ovarian cancer blood test is far more predictive than originally thought and could potentially pick up other forms of cancer.
This autumn the chancellor Rishi Sunak will set out the Government’s spending priorities. Here’s why it’s time to invest in cancer services and research.
We’ve estimated it will cost HEE between £142 million and £260 million more than it already invests to grow the key cancer professions by 45%.
Six months since lockdown, we’ve got a much clearer picture how cancer services were affected, and how well they’re recovering.
Looking at the latest results from the BEST3 trial, analysing the ‘sponge-on-a-string’ test to detect oesophageal cancer earlier.
Cancer Research UK scientists have developed a new way to analyse blood for evidence of cancer that could be up to ten times more sensitive than previous methods.
Cancer services have been severely disrupted across the UK, from screening to treatment and care.
Researchers have revealed a new blood test that uses artificial intelligence to identify cancer, but it’s not ready for patients yet.